Franck Touret

Associate professor

Institut de Recherche pour le Développement

France

Research Interests

Explore related searches

Professors in France

Contact this professor

ORCID

Google Scholar

Articles (10)

Neutralizing and enhancing monoclonal antibodies in SARS-CoV-2 convalescent patients: lessons from early variant infection and impact on shaping emerging variants

Article Link

Year:

2024

From the “One-Molecule, One-Target, One-Disease” Concept towards Looking for Multi-Target Therapeutics for Treating Non-Polio Enterovirus (NPEV) Infections

Article Link

Year:

2024

New potent EV-A71 antivirals targeting capsid.

Article Link

Year:

2024

Current status of pathogen handling in European laboratories: focus on viral inactivation process.

Article Link

Year:

2024

Preclinical in vivo assessment of the activity of AZD7442 anti-SARS-CoV-2 monoclonal antibodies against Omicron sublineages.

Article Link

Year:

2024

Broad-spectrum dengue virus detection using the commercial RealStar dengue RT-PCR kit 3.0 (Altona) and an in-house combined real-time RT-PCR assay.

Article Link

Year:

2024

Further preclinical characterization of molnupiravir against SARS-CoV-2: Antiviral activity determinants and viral genome alteration patterns

Article Link

Year:

2024

Generation and evaluation of protease inhibitor-resistant SARS-CoV-2 strains.

Article Link

Year:

2024

Structure-guided optimization of adenosine mimetics as selective and potent inhibitors of coronavirus nsp14 N7-methyltransferases

Article Link

Year:

2023

Hybrid molecules based on an emodin scaffold. Synthesis and activity against SARS-CoV-2 and <i>Plasmodium</i>.

Article Link

Year:

2023

Collaborators (3)

Françoise Debart

University of Montpellier

FRANCE

sarah barelier

INSERM

FRANCE

Etienne Decroly

Aix-Marseille University

FRANCE

Franck Touret

Research Interests

Explore related searches

Contact this professor

Articles (10)

Neutralizing and enhancing monoclonal antibodies in SARS-CoV-2 convalescent patients: lessons from early variant infection and impact on shaping emerging variants

From the “One-Molecule, One-Target, One-Disease” Concept towards Looking for Multi-Target Therapeutics for Treating Non-Polio Enterovirus (NPEV) Infections

New potent EV-A71 antivirals targeting capsid.

Current status of pathogen handling in European laboratories: focus on viral inactivation process.

Preclinical in vivo assessment of the activity of AZD7442 anti-SARS-CoV-2 monoclonal antibodies against Omicron sublineages.

Broad-spectrum dengue virus detection using the commercial RealStar dengue RT-PCR kit 3.0 (Altona) and an in-house combined real-time RT-PCR assay.

Further preclinical characterization of molnupiravir against SARS-CoV-2: Antiviral activity determinants and viral genome alteration patterns

Generation and evaluation of protease inhibitor-resistant SARS-CoV-2 strains.

Structure-guided optimization of adenosine mimetics as selective and potent inhibitors of coronavirus nsp14 N7-methyltransferases

Hybrid molecules based on an emodin scaffold. Synthesis and activity against SARS-CoV-2 and <i>Plasmodium</i>.

Collaborators (3)

Françoise Debart

sarah barelier

Etienne Decroly

How do I reach out?

Meet Kite AI